In contrast, the increased expression level of GPR132 (P = 0.014) predicted a superior prognosis, suggesting a potential protective role of GPR132 in AML (Fig. 1C, Supplemental Fig. S1B, Supplemental Table S3). The gene discussed is GPR132; the disease is acute myeloid leukemia.